These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 37070985)

  • 41. Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine.
    Liu Y; Tong Z; Shi J; Jia Y; Deng T; Wang Z
    Commun Biol; 2021 Nov; 4(1):1328. PubMed ID: 34824393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developments on antibiotics for multidrug resistant bacterial Gram-negative infections.
    Voulgaris GL; Voulgari ML; Falagas ME
    Expert Rev Anti Infect Ther; 2019 Jun; 17(6):387-401. PubMed ID: 31006284
    [No Abstract]   [Full Text] [Related]  

  • 43. A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.
    Sick-Samuels AC; Goodman KE; Rapsinski G; Colantouni E; Milstone AM; Nowalk AJ; Tamma PD
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):142-149. PubMed ID: 30690525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonlethal Molecular Nanomachines Potentiate Antibiotic Activity Against Gram-Negative Bacteria by Increasing Cell Permeability and Attenuating Efflux.
    Santos AL; Liu D; van Venrooy A; Beckham JL; Oliver A; Tegos GP; Tour JM
    ACS Nano; 2024 Jan; 18(4):3023-3042. PubMed ID: 38241477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interplay between three RND efflux pumps in doxycycline-selected strains of Burkholderia thailandensis.
    Biot FV; Lopez MM; Poyot T; Neulat-Ripoll F; Lignon S; Caclard A; Thibault FM; Peinnequin A; Pagès JM; Valade E
    PLoS One; 2013; 8(12):e84068. PubMed ID: 24386333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of Novel Pyridone-Conjugated Monosulfactams as Potent and Broad-Spectrum Antibiotics for Multidrug-Resistant Gram-Negative Infections.
    Tan L; Tao Y; Wang T; Zou F; Zhang S; Kou Q; Niu A; Chen Q; Chu W; Chen X; Wang H; Yang Y
    J Med Chem; 2017 Apr; 60(7):2669-2684. PubMed ID: 28287720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
    Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
    Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.
    Tängdén T
    Ups J Med Sci; 2014 May; 119(2):149-53. PubMed ID: 24666223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New Multidrug Efflux Inhibitors for Gram-Negative Bacteria.
    Marshall RL; Lloyd GS; Lawler AJ; Element SJ; Kaur J; Ciusa ML; Ricci V; Tschumi A; Kühne H; Alderwick LJ; Piddock LJV
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of β-Ketoacyl Acyl Carrier Protein Synthase III Activity Restores Multidrug-Resistant Escherichia coli Sensitivity to Previously Ineffective Antibiotics.
    Hong Y; Qin J; Verderosa AD; Hawas S; Zhang B; Blaskovich MAT; Cronan JE; Totsika M
    mSphere; 2022 Jun; 7(3):e0011722. PubMed ID: 35574679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pentamidine sensitizes FDA-approved non-antibiotics for the inhibition of multidrug-resistant Gram-negative pathogens.
    Wu C; Xia L; Huang W; Xu Y; Gu Y; Liu C; Ji L; Li W; Wu Y; Zhou K; Feng X
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1771-1779. PubMed ID: 32242313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
    Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
    Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New understanding of multidrug efflux and permeation in antibiotic resistance, persistence, and heteroresistance.
    Manrique PD; López CA; Gnanakaran S; Rybenkov VV; Zgurskaya HI
    Ann N Y Acad Sci; 2023 Jan; 1519(1):46-62. PubMed ID: 36344198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.
    Hawkey PM; Warren RE; Livermore DM; McNulty CAM; Enoch DA; Otter JA; Wilson APR
    J Antimicrob Chemother; 2018 Mar; 73(suppl_3):iii2-iii78. PubMed ID: 29514274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens.
    Tomaras AP; McPherson CJ; Kuhn M; Carifa A; Mullins L; George D; Desbonnet C; Eidem TM; Montgomery JI; Brown MF; Reilly U; Miller AA; O'Donnell JP
    mBio; 2014 Sep; 5(5):e01551-14. PubMed ID: 25271285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' Polymyxins.
    Paterson DL; Bonomo RA
    Adv Exp Med Biol; 2019; 1145():9-13. PubMed ID: 31364068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics.
    Clancy CJ; Nguyen MH
    Infect Dis Clin North Am; 2022 Dec; 36(4):791-823. PubMed ID: 36328637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.